# Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis

> **NCT01408082** · PHASE3 · COMPLETED · sponsor: **Sun Pharmaceutical Industries Limited** · enrollment: 917 (actual)

## Conditions studied

- Blepharitis

## Interventions

- **DRUG:** ISV-502 (1.0% azithromycin and 0.1% dexamethasone combined)
- **DRUG:** Azasite
- **DRUG:** Dexamethasone
- **OTHER:** Vehicle

## Key facts

- **NCT ID:** NCT01408082
- **Lead sponsor:** Sun Pharmaceutical Industries Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-03
- **Final completion:** 2013-06
- **Target enrollment:** 917 (ACTUAL)
- **Last updated:** 2021-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01408082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01408082, "Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01408082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*